Idiopathic Thrombocytopenic Purpura Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Corticosteroids, IVIG, Anti-D Immunoglobulins, TPO-RA, Others), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                          1.1.1. Disease Type
                          1.1.2. Product
                          1.1.3. Regional scope
                          1.1.4. Estimates and forecast timeline
                      1.2. Research Methodology
                      1.3. Information Procurement
                          1.3.1. Purchased database
                          1.3.2. GVR’s internal database
                          1.3.3. Secondary sources
                          1.3.4. Primary research
                          1.3.5. Details of primary research
                      1.4. Information or Data Analysis
                          1.4.1. Data analysis models
                      1.5. Market Formulation & Validation
                      1.6. Model Details
                      1.7. List of Secondary Sources
                      1.8. List of Primary Sources
                      1.9. Objectives
                          1.9.1. Objective 1
                          1.9.2. Objective 2
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Disease type outlook
                          2.2.2. Product outlook
                          2.2.3. Regional outlook
                      2.3. Competitive Insights
Chapter 3. Idiopathic Thrombocytopenic Purpura Therapeutics Market Variables, Trends & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Penetration & Growth Prospect Mapping
                      3.3. Market Dynamics
                          3.3.1. Market driver analysis
                          3.3.2. Market restraint analysis
                      3.4. Idiopathic Thrombocytopenic Purpura Therapeutics Market Analysis Tools
                          3.4.1. Industry Analysis – Porter’s
                              3.4.1.1. Supplier power
                              3.4.1.2. Buyer power
                              3.4.1.3. Substitution threat
                              3.4.1.4. Threat of new entrant
                              3.4.1.5. Competitive rivalry
                          3.4.2. PESTEL Analysis
                              3.4.2.1. Political landscape
                              3.4.2.2. Technological landscape
                              3.4.2.3. Economic landscape
Chapter 4. Idiopathic Thrombocytopenic Purpura Therapeutics Market: Disease Type Estimates & Trend Analysis
                      4.1. Idiopathic Thrombocytopenic Purpura Therapeutics Market, By Disease Type Key Takeaways
                      4.2. Idiopathic Thrombocytopenic Purpura Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
                      4.3. Acute ITP
                          4.3.1. Acute ITP market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.4. Chronic
                          4.4.1. Chronic market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.5. Others
                          4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Idiopathic Thrombocytopenic Purpura Therapeutics Market: Product Estimates & Trend Analysis
                      5.1. Idiopathic Thrombocytopenic Purpura Therapeutics Market, By Product Key Takeaways
                      5.2. Idiopathic Thrombocytopenic Purpura Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
                      5.3. Corticosteroids
                          5.3.1. Corticosteroids market estimates and forecasts, 2018 to 2030 (USD Million)
                      5.4. IVIG
                          5.4.1. IVIG market estimates and forecasts, 2018 to 2030 (USD Million)
                      5.5. Anti-D Immunoglobulins
                          5.5.1. Anti-D Immunoglobulins market estimates and forecasts, 2018 to 2030 (USD Million)
                      5.6. TPO-RA
                          5.6.1. TPO-RA market estimates and forecasts, 2018 to 2030 (USD Million)
                      5.7. Others
                          5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Idiopathic Thrombocytopenic Purpura Therapeutics Market: Regional Estimates & Trend Analysis
                      6.1. Regional Outlook
                      6.2. Idiopathic Thrombocytopenic Purpura Therapeutics Market by Region: Key Marketplace Takeaway
                      6.3. North America
                          6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.3.2. U.S.
                              6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.3.3. Canada
                              6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      6.4. Europe
                         6.4.1. U.K.
                              6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.2. Germany
                              6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.3. France
                              6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.4. Italy
                              6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.5. Spain
                              6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.6. Sweden
                              6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.7. Norway
                              6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.4.8. Denmark
                              6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      6.5. Asia Pacific
                          6.5.1. Japan
                              6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.5.2. China
                              6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.5.3. India
                              6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.5.4. Australia
                              6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.5.5. Thailand
                              6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.5.6. South Korea
                              6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      6.6. Latin America
                          6.6.1. Brazil
                              6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.6.2. Mexico
                              6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.6.3. Argentina
                              6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      6.7. MEA
                          6.7.1. Saudi Arabia
                              6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.7.2. South Africa
                              6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.7.3. UAE
                              6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          6.7.4. Kuwait
                              6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
                      7.1. Recent Developments & Impact Analysis, By Key Market Participants
                      7.2. Company/Competition Categorization
                          7.2.1. Amgen Inc.
                              7.2.1.1. Company overview
                              7.2.1.2. Financial performance
                              7.2.1.3. Disease Type benchmarking
                              7.2.1.4. Strategic initiatives
                         7.2.2. F. Hoffmann-La Roche Ltd
                              7.2.2.1. Company overview
                              7.2.2.2. Financial performance
                              7.2.2.3. Disease Type benchmarking
                              7.2.2.4. Strategic initiatives
                          7.2.3. Grifols, S.A.
                              7.2.3.1. Company overview
                              7.2.3.2. Financial performance
                              7.2.3.3. Disease Type benchmarking
                              7.2.3.4. Strategic initiatives
                          7.2.4. GSK plc.
                              7.2.4.1. Company overview
                              7.2.4.2. Financial performance
                              7.2.4.3. Disease Type benchmarking
                              7.2.4.4. Strategic initiatives
                          7.2.5. Shangxian Minimal Invassive Inc.
                              7.2.5.1. Company overview
                              7.2.5.2. Financial performance
                              7.2.5.3. Disease Type benchmarking
                              7.2.5.4. Strategic initiatives
                          7.2.6. INTROMEDIC
                              7.2.6.1. Company overview
                              7.2.6.2. Financial performance
                              7.2.6.3. Disease Type benchmarking
                              7.2.6.4. Strategic initiatives
                          7.2.7. Medtronic
                              7.2.7.1. Company overview
                              7.2.7.2. Financial performance
                              7.2.7.3. Disease Type benchmarking
                              7.2.7.4. Strategic initiatives
                          7.2.8. FUJIFILM Holdings Corporation
                              7.2.8.1. Company overview
                              7.2.8.2. Financial performance
                              7.2.8.3. Disease Type benchmarking
                              7.2.8.4. Strategic initiatives
                          7.2.9. Olympus Corporation
                              7.2.9.1. Company overview
                              7.2.9.2. Financial performance
                              7.2.9.3. Disease Type benchmarking
                              7.2.9.4. Strategic initiatives
                          7.2.10. JINSHAN Science & Technology (Group) Co., Ltd.
                              7.2.10.1. Company overview
                              7.2.10.2. Financial performance
                              7.2.10.3. Disease Type benchmarking
                              7.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 3 North America idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 North America idiopathic thrombocytopenic purpura therapeutics market, by country, 2018 - 2030 (USD Million)
Table 5 U.S. idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 6 U.S. idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 7 Canada idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 8 Canada idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 9 Europe idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 10 Europe idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 Europe idiopathic thrombocytopenic purpura therapeutics market, by country, 2018 - 2030 (USD Million)
Table 12 Germany idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 13 Germany idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 14 UK idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 15 UK idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 16 France idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 17 France idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 18 Italy idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 19 Italy idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 20 Spain idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 21 Spain idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 22 Denmark idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 23 Denmark idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 24 Sweden idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 25 Sweden idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 26 Norway idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 27 Norway idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 28 Asia Pacific idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific idiopathic thrombocytopenic purpura therapeutics market, by country, (USD Million) 2018 - 2030
Table 31 Japan idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 32 Japan idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 33 China idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 34 China idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 35 India idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 36 India idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 37 Thailand idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 38 Thailand idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 39 South Korea idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 40 South Korea idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 41 Latin America idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 42 Latin America idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 43 Latin America idiopathic thrombocytopenic purpura therapeutics market, by country, 2018 - 2030 (USD Million)
Table 44 Brazil idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 45 Brazil idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 46 Mexico idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 47 Mexico idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 48 Argentina idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 49 Argentina idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 50 Middle East and Africa idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 51 Middle East and Africa idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa idiopathic thrombocytopenic purpura therapeutics market, by country, (USD Million) 2018 - 2030
Table 53 Saudi Arabia idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 55 South Africa idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 56 South Africa idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 57 UAE idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 58 UAE idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)
Table 59 Kuwait idiopathic thrombocytopenic purpura therapeutics market, by disease type, 2018 - 2030 (USD Million)
Table 60 Kuwait idiopathic thrombocytopenic purpura therapeutics market, by product, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Idiopathic thrombocytopenic purpura therapeutics: market outlook
Fig. 9 Idiopathic thrombocytopenic purpura therapeutics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Idiopathic thrombocytopenic purpura therapeutics market driver impact
Fig. 15 Idiopathic thrombocytopenic purpura therapeutics market restraint impact
Fig. 16 Idiopathic thrombocytopenic purpura therapeutics market strategic initiatives analysis
Fig. 17 Idiopathic thrombocytopenic purpura therapeutics market: Disease type movement analysis
Fig. 18 Idiopathic thrombocytopenic purpura therapeutics market: Disease type outlook and key takeaways
Fig. 19 Acute ITP market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Chronic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Idiopathic thrombocytopenic purpura therapeutics market: Product type movement analysis
Fig. 23 Idiopathic thrombocytopenic purpura therapeutics market: Product type outlook and key takeaways
Fig. 24 OGIB market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 IVIG market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Anti-D immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 TPO-RA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Global idiopathic thrombocytopenic purpura therapeutics market: Regional movement analysis
Fig. 30 Global idiopathic thrombocytopenic purpura therapeutics market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)